Clin Mol Hepatol.
2023 Apr;29(2):339-341. 10.3350/cmh.2023.0077.
The clinical management of hepatocellular carcinoma in China: Progress and challenges
- Affiliations
-
- 1Liver Research Center, Beijing Friendship Hospital, Capital Medical University; The National Clinical Research Center for Digestive Diseases, Beijing, China
- KMID: 2541411
- DOI: http://doi.org/10.3350/cmh.2023.0077
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Management of hepatocellular carcinoma in China: Seeking common grounds while reserving differences
- The prime time for management of hepatocellular carcinoma in Hong Kong
- Management of early-stage hepatocellular carcinoma: challenges and strategies for optimal outcomes
- Meeting the challenges of hepatocellular carcinoma post sustained virologic response in the post-direct- acting antiviral era: A path forward: Editorial on “Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication”
- Combined Hepatocellular-Cholangiocarcinoma: Recent Progress in Pathology and Classification
